Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetes

Aims/Introduction To define a set of criteria using indices of β‐cell function, including results from the glucagon stimulation test, for liraglutide introduction in patients with type 2 diabetes. Materials and Methods In the present retrospective cohort study, patients were included in our analysis if their β‐cell function had been evaluated with a glucagon stimulation test and a 24‐h urinary C ‐peptide ( U ‐ CPR ) excretion test before...